{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:47:59Z","timestamp":1793785679841,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtct.2026.04.016","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:32:39Z","timestamp":1776468759000},"page":"909-923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fecal Microbiota Transplantation for Gastrointestinal Complications After Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Narrative Synthesis"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9096-5132","authenticated-orcid":false,"given":"Shan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jtct.2026.04.016_bib0001","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3324\/haematol.2020.265769","article-title":"Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study","volume":"107","author":"Greinix","year":"2022","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.jtct.2026.04.016_bib0002","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","article-title":"The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation","volume":"124","author":"Taur","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.016_bib0003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, Multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.04.016_bib0004","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.4103\/jcrt.jcrt_33_24","article-title":"The role of fecal microbiota transplantation in the treatment of acute graft-versus-host disease","volume":"20","author":"Guo","year":"2024","journal-title":"J Cancer Res Ther"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.016_bib0005","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1007\/s00277-023-05460-7","article-title":"The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"102","author":"Wang","year":"2023","journal-title":"Ann Hematol"},{"issue":"556","key":"10.1016\/j.jtct.2026.04.016_bib0006","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz8926","article-title":"Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients","volume":"12","author":"van Lier","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtct.2026.04.016_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1509612","article-title":"Microbiota modulation for infectious complications following allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies","volume":"13","author":"Dai","year":"2025","journal-title":"Front Pediatr"},{"issue":"6145","key":"10.1016\/j.jtct.2026.04.016_bib0008","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jtct.2026.04.016_bib0009","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbmt.2016.02.009","article-title":"Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem cell transplantation: a retrospective, single-center study","volume":"22","author":"Bilinski","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.04.016_bib0010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.016_bib0011","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","article-title":"Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation","volume":"23","author":"Weber","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.016_bib0012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(15)00462-3","article-title":"Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial","volume":"17","author":"Walker","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.016_bib0013","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15186","article-title":"Expert consensus on the relevance of intestinal microecology and hematopoietic stem cell transplantation","volume":"38","author":"Wang","year":"2024","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.016_bib0014","first-page":"648","article-title":"Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients","volume":"16","author":"Panahi","year":"2024","journal-title":"Iran J Microbiol"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.016_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/s12916-025-04336-z","article-title":"Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study","volume":"23","author":"Yang","year":"2025","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.jtct.2026.04.016_bib0016","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1182\/bloodadvances.2018017731","article-title":"Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity","volume":"2","author":"DeFilipp","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.016_bib0017","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/tid.12550","article-title":"Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients","volume":"18","author":"Webb","year":"2016","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.jtct.2026.04.016_bib0018","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211058333","article-title":"Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study","volume":"12","author":"Spindelboeck","year":"2021","journal-title":"Ther Adv Hematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.04.016_bib0019","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3324\/haematol.2018.198549","article-title":"Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria","volume":"104","author":"Battipaglia","year":"2019","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.016_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5005\/jp-journals-10071-24607","article-title":"Fecal microbiota transplantation for Clostridium difficile-associated diarrhea in hematopoietic stem cell transplant recipients: a single-center experience from a tertiary center in India","volume":"28","author":"Prayag","year":"2024","journal-title":"Indian J Crit Care Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.016_bib0021","doi-asserted-by":"crossref","first-page":"E88","DOI":"10.1002\/ajh.26077","article-title":"Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease\u2014spectrum of responses and safety profile. Results from a prospective, multicenter study","volume":"96","author":"Bilinski","year":"2021","journal-title":"Am J Hematol"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.04.016_bib0022","doi-asserted-by":"crossref","first-page":"4884.","DOI":"10.1182\/blood-2021-147777","article-title":"Efficacy and safety of fecal microbiota transplantation in the treatment of acute and chronic steroid-refractory graft-versus-host disease after hematopoietic stem cell transplantation","volume":"138","author":"Huang","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.04.016_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102111","article-title":"Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial","volume":"62","author":"Malard","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.04.016_bib0024","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1182\/blood-2024-201251","article-title":"Pooled fecal allogenic microbiotherapy for refractory gastrointestinal acute graft-versus-host disease : results from Early Access Program in Europe","volume":"144","author":"Malard","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.016_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ejh.13642","article-title":"Fecal microbiota transfer for refractory intestinal graft-versus-host disease\u2014experience from two German tertiary centers","volume":"107","author":"Goeser","year":"2021","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.016_bib0026","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41467-025-56375-y","article-title":"Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect","volume":"16","author":"Reddi","year":"2025","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jtct.2026.04.016_bib0027","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/bloodadvances.2024012556","article-title":"Third-party fecal microbiota transplantation for high-risk treatment-na\u00efve acute GVHD of the lower GI tract","volume":"8","author":"DeFilipp","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.016_bib0028","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41409-024-02198-2","article-title":"Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study","volume":"59","author":"Youngster","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.016_bib0029","first-page":"401","article-title":"Clinical study of 19 cases of steroid-refractory gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with fecal microbiota transplantation","volume":"44","author":"Zheng","year":"2023","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.jtct.2026.04.016_bib0030","article-title":"Safety and efficacy of fecal microbiota transplantation for grade IV steroid refractory GI-GvHD patients: interim results from FMT2017002 trial","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"issue":"460","key":"10.1016\/j.jtct.2026.04.016_bib0031","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9489","article-title":"Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant","volume":"10","author":"Taur","year":"2018","journal-title":"Sci Transl Med"},{"issue":"34","key":"10.1016\/j.jtct.2026.04.016_bib0032","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1200\/JCO.22.02366","article-title":"Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML","volume":"41","author":"Rashidi","year":"2023","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jtct.2026.04.016_bib0033","first-page":"43","article-title":"Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety","volume":"92","author":"Goloshchapov","year":"2020","journal-title":"Ter Arkh"},{"issue":"11","key":"10.1016\/j.jtct.2026.04.016_bib0034","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/ijms25115789","article-title":"Alteration of gut microbiota composition and diversity in acute and\/or chronic graft-versus-host disease following hematopoietic stem cell transplantation: a prospective cohort study","volume":"25","author":"Gavriilaki","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.jtct.2026.04.016_bib0035","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2016-05-717652","article-title":"Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut","volume":"128","author":"Kakihana","year":"2016","journal-title":"Blood"},{"issue":"6469","key":"10.1016\/j.jtct.2026.04.016_bib0036","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.aax3760","article-title":"Lactose drives Enterococcus expansion to promote graft-versus-host disease","volume":"366","author":"Stein-Thoeringer","year":"2019","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.016_bib0037","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1016\/j.bbmt.2020.01.019","article-title":"Enterococcus: a predictor of ravaged microbiota and poor prognosis after allogeneic hematopoietic stem cell transplantation","volume":"26","author":"Kusakabe","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.016_bib0038","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ni.3400","article-title":"Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease","volume":"17","author":"Mathewson","year":"2016","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.016_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2018.03.002","article-title":"Nutritional support from the intestinal microbiota improves hematopoietic reconstitution after bone marrow transplantation in mice","volume":"23","author":"Staffas","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.016_bib0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40164-022-00350-6","article-title":"Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD","volume":"11","author":"Liu","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.016_bib0041","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1186\/s12967-025-06797-5","article-title":"The microbiome in graft-versus-host disease: a tale of two ecosystems","volume":"23","author":"Soleimani Samarkhazan","year":"2025","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.016_bib0042","doi-asserted-by":"crossref","first-page":"272.e1","DOI":"10.1016\/j.jtct.2020.12.011","article-title":"Vedolizumab for steroid refractory lower gastrointestinal tract graft-versus-host disease","volume":"27","author":"Mehta","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.016_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068480","article-title":"Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study)","volume":"13","author":"Doug\u00e9","year":"2023","journal-title":"BMJ Open"},{"issue":"339","key":"10.1016\/j.jtct.2026.04.016_bib0044","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2311","article-title":"Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice","volume":"8","author":"Shono","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.016_bib0045","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1038\/s41467-021-23376-6","article-title":"Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients","volume":"12","author":"Malard","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.016_bib0046","doi-asserted-by":"crossref","first-page":"e6799","DOI":"10.1002\/cam4.6799","article-title":"Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease","volume":"13","author":"Yue","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.016_bib0047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/cid\/ciz777","article-title":"Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia","volume":"71","author":"Galloway-Pe\u00f1a","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.016_bib0048","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood.2019000950","article-title":"Microbiome-intestine cross talk during acute graft-versus-host disease","volume":"136","author":"Rafei","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.016_bib0049","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.3390\/biomedicines11123274","article-title":"Autologous faecal microbiota transplantation to improve outcomes of haematopoietic stem cell transplantation: results of a single-centre feasibility study","volume":"11","author":"Li","year":"2023","journal-title":"Biomedicines"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:50:39Z","timestamp":1785883839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726003039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666636726003039"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.016","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal Microbiota Transplantation for Gastrointestinal Complications After Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Narrative Synthesis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}